Analytics

Biologics Quality Control: The Growing Need for Accessible Proteomics

There is a great need for sensitive, precise, and easily accessible analytical detection techniques for protein sequencing.

Emerging Therapies Drive Analytical Advancements

The emergence of mRNA vaccines and cell and gene therapies has pushed innovation in analytical methods.

Analyzing Exabytes

Effective analytics will eliminate failures, deviations, and non-conformances.

The Importance of HCP Monitoring

July 04, 2024

HCPs are major process-related impurities that must be monitored throughout biologics production for clearance.

CO2 Incubators

July 01, 2024

The VIOS family of incubators are known for optimal cell growth conditions and minimal contamination risk.

Reviewing the Categories of Substance Tests

June 25, 2024

Here, Pavan Kumar Kunala from Almac Sciences runs through the different types of tests used to analyze drug substances to ensure quality and safety.

Dissecting Dissolution Testing

June 20, 2024

Advances in dissolution testing equipment are helping to meet user demands to a certain degree; however, more innovation in the space may be necessary for novel therapies, such as biologics.

Thermo Fisher Opens New Building at Wisconsin GMP Lab

June 19, 2024

The $58 million investment has resulted in a 72,000-square-foot facility with a dedicated LC–MS space and molecular suites and will bring as many as 350 new jobs onto the campus.

Determination of Shelf-Life from Stability Data: From Replicates or from Averages?

June 11, 2024

A statistical analysis for determining an expiration date can be applied to replicates or their corresponding averages as suggested in industry guidelines.

Reviewing the Importance of Biosimilarity and Interchangeability

June 06, 2024

Biosimilar analytical assessments focus on demonstrating biosimilarity and interchangeability with the reference biologic.

Applying AI to Molecular Structure (BIO 2024)

June 06, 2024

Founder and CEO of Atomic AI, Raphael Townshend, explores AI’s usefulness as a tool to characterize molecular structure and advance molecule engineering.

A Look at Translational CROs and PDC Modeling (BIO 2024)

June 06, 2024

Andrew Carnegie, head of Strategic Commercial Development at Inaphaea BioLabs, discusses the establishment of translational CROs and the role of PDC models in the drug discovery process.

The Intersection of Chemistry, Robotics, and AI in Drug Discovery (BIO 2024)

June 05, 2024

Lee Cronin, founder and CEO of Chemify, discusses the combination of digital chemistry, robotics, and AI in the drug discovery space.